Biotron Limited Updates Timetable for Securities Issue

Biotron Limited ( (AU:BIT) ) has shared an update.

Biotron Limited has announced an update to its proposed issue of securities, revising the timetable for its rights issue. The revised schedule includes key dates such as the record date on March 6, 2025, the opening of the offer on March 18, 2025, and the expected commencement of normal trading of new shares on April 9, 2025. This update is significant for stakeholders as it outlines the timeline for the rights issue process, impacting shareholders and potential investors by providing clarity on the investment opportunity and the company’s capital raising efforts.

More about Biotron Limited

Biotron Limited operates in the biotechnology industry, focusing on the development of innovative antiviral therapies. The company is primarily engaged in researching and developing treatments for serious viral infections, with a market focus on addressing unmet medical needs in this area.

YTD Price Performance: 390.0%

Average Trading Volume: 31,750

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $3.41M

For detailed information about BIT stock, go to TipRanks’ Stock Analysis page.